Search - tctmd.com

Displaying 301 - 320 of 498

Sort: Relevancy | Date

News Daily News

丹麦的一项研究揭示了NSTEMI、不稳定型心绞痛的治疗和结果的社会经济差距

Yael L. Maxwell

September 25, 2015

News Daily News

Un Estudio Danés Revela la Disparidad Socioeconómica en el Tratamiento y Resultados de los Cuadros de NSTEMI y Angina Inestable

Yael L. Maxwell

September 25, 2015

News Daily News

Danish Study Reveals Socioeconomic Disparity in Treatment, Outcomes for NSTEMI, Unstable Angina

Yael L. Maxwell

September 25, 2015

Presentation

Does Access to Invasive Examination and Treatment Influence Socioeconomic Differences in Case Fatality for Pts Admitted with NSTEMI or Unstable Angina?

Presenter: Solvej M?rtensson

September 24, 2015

News Conference News ESC 2015

High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures

L.A. McKeown

September 02, 2015

News Conference News ESC 2015

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

Yael L. Maxwell

September 01, 2015

News Conference News ESC 2015

TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics

Yael L. Maxwell

August 31, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

L.A. McKeown

August 17, 2015

News Daily News

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Todd Neale

August 17, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

News Industry News

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

July 23, 2015

News Industry News

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Industry News

St. Jude Medical Announces Launch of the First International Trial to Compare OCT-Guided Stent Implantation to IVUS or Angiography-Guided PCI

June 30, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

Advertisement

丹麦的一项研究揭示了NSTEMI、不稳定型心绞痛的治疗和结果的社会经济差距

Un Estudio Danés Revela la Disparidad Socioeconómica en el Tratamiento y Resultados de los Cuadros de NSTEMI y Angina Inestable

Danish Study Reveals Socioeconomic Disparity in Treatment, Outcomes for NSTEMI, Unstable Angina

Does Access to Invasive Examination and Treatment Influence Socioeconomic Differences in Case Fatality for Pts Admitted with NSTEMI or Unstable Angina?

High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

ILUMIEN I Published: OCT Can Affect PCI Strategy

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Lilly Provides Update on Evacetrapib Phase 3 Trial

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

St. Jude Medical Announces Launch of the First International Trial to Compare OCT-Guided Stent Implantation to IVUS or Angiography-Guided PCI

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content